KRAS cancer drug eased symptoms of rare and serious blood vessel condition in two patients, new study shows
The advent of new targeted oncology therapies may benefit more than just cancer patients.
Two patients with severe arteriovenous malformations — an ultra-rare condition where a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
